An Overview of Neuroprotective Mechanism of Methylene Blue

Duration: 28:25

Write A New Comment

2 Comments

22knowing@*.com

May 21 2025, 1:11 pm

I believe this is a hit piece. It is attributing MB as being just an MAO and giving data of MAO's versus what low-dose MB and its diverse uses have been and used for. It also talks about the serotonin overdosing which I have read has only happened in one documented case where methylene blue was used to irrigate a surgical incision to find either a nerve or blood vessel and that person was on SSRIs. Anything we put into our bodies we can be allergic to, anything that is put into our bodies in overdosed form can be toxic to different variations. I'm sure Dr Been has addressed the issue of headpieces, just like ivermectin, hydroxychloroquine where studies were done knowingly that killed people to try and propagandize repurpose drugs that actually help humanity and are accessible with profound safety compared to what is on the market now. It is such a criminal act for research to knowingly be done that harms people and keeps humanity from getting safe accessible alternatives because of the greed of the monopolies These days, yet they get away with it. Thanks Dr Been regardless, I'm struggling to get my ex executive functioning skills back obviously ❤️🙏❤️

kebera@*.com

May 19 2025, 7:17 pm

There is an "emergency notification" making the rounds about this stuff. I wonder if you or the knowledgable CoolBeens here could evaluate for credibility and applicability. https://gingerbreggin.substack.com/p/emergency-notification-methylene

Animal studies have demonstrated the neuroprotective role of methylene blue especially when administered within an hour of transient ischemic insult of the neurons. Methylene blue is antioxidant, anti-inflammatory, and induces autophagy while reducing apoptosis. Let's review its mechanisms.

Contraindications: https://www.rxlist.com/consumer_provayblue_methylene_blue/drugs-condition.htm

The Effects of Methylene Blue on Autophagy and Apoptosis in MRI-Defined Normal Tissue, Ischemic Penumbra and Ischemic Core | PLOS ONE https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0131929

AMPK - Legere Pharmaceuticals https://www.legerepharm.com/ampk/

Schematic illustration of the mTOR signaling pathway. AMPK indicates... | Download Scientific Diagram https://www.researchgate.net/figure/Schematic-illustration-of-the-mTOR-signaling-pathway-AMPK-indicates-AMP-activated_fig1_228089413

Model of the AMPK and mTOR signaling network in mammalian cells. AMPK... | Download Scientific Diagram https://www.researchgate.net/figure/Model-of-the-AMPK-and-mTOR-signaling-network-in-mammalian-cells-AMPK-inhibits-mTOR_fig1_221865491

Frontiers | Protection against neurodegeneration with low-dose methylene blue and near-infrared light https://www.frontiersin.org/articles/10.3389/fncel.2015.00179/full

Mitochondria as a target for neuroprotection: role of methylene blue and photobiomodulation | Translational Neurodegeneration | Full Text https://translationalneurodegeneration.biomedcentral.com/articles/10.1186/s40035-020-00197-z

Following answers are created by ChatGPT. Occasionally the answer may be harmful, incorrect, false, misleading, incomplete, or limited in knowledge of world. Please contact your doctor for all healthcare decisions. Also, double check the answer provided by the AI below.

Faculty

In addition to the presenter, following authors may have helped with the content writing, review, or approval:

Dr. Mobeen Syed

CME, CE, CEU and Other Credit Types:

ACCME Accreditation Statement
The DrBeen Corp is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA Credit Designation Statement
The DrBeen Corp designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Information

In accordance with the disclosure policies of DrBeen Corp and the ACCME (Accreditation Council for Continuing Medical Education), we are committed to upholding principles of balance, independence, objectivity, and scientific rigor in all of our Continuing Medical Education (CME) and Continuing Education (CE) activities. These policies include the careful management and mitigation of any relevant financial relationships with organizations that are not eligible.
All members of the Activity Planning Committee and presenters have disclosed their relevant financial relationships. The DrBeen Corp CE Committee has thoroughly reviewed these disclosures and determined that these relationships are not deemed inappropriate in the context of their respective presentations. Additionally, they are found to be consistent with the educational objectives and the integrity of the activity.

Faculty	Disclosures
Dr. Mobeen Syed	Author declares no conflict of interest.

Please login to access this content.

Don't have an account?

See Plans

Instructors

Dr. Mobeen Syed

MD., MSc., MSc., BSc

Mobeen Syed is the CEO of DrBeen Corp, a modern online medical education marketplace. Mobeen is a medical doctor and a software engineer. He graduated from the prestigious King Edward Medical University Lahore. He has been teaching medicine since 1994. Mobeen is also a software engineer and engineering leader. In this role, Mobeen has run teams consisting of hundreds of engineers and millions of dollars of budgets. Mobeen loves music, teaching, and doing business. He lives in Cupertino CA.